ComOps, a leading Australian provider of business software products and services, has secured a contract to deploy a corporate performance reporting solution for Enterix, a wholly-owned subsidiary of Quest Diagnostics Incorporated.  Enterix Australia manufactures the line of InSure® FIT fecal immunochemical tests sold in Australia and internationally as an aid in colorectal (bowel) cancer screening.  

Enterix will deploy ComOps' modular Corporate Performance Reporting solution, including ComOps BI (business intelligence) for operational reports and analysis, ComOps Dashboard for management reports and KPI performance, and ComOps CRS (Corporate Reporting Services) for patient diagnosis report collation.

Following a review of several market solutions, ComOps was chosen for its ability to automate previously time-consuming processes and provide a single source of financial information from all parts of the Enterix business in Australia for reporting to Quest Diagnostics Incorporated, based in Madison, New Jersey, U.S.
 
“We chose ComOps following a careful review that included assessing recommendations from other organisations,” said Judy Readman, General Manager, Enterix. “While the proposed solution includes the reporting and dashboard features we require of a cost-effective reporting platform, we also selected ComOps based on their ability to respond rapidly and flexibly in meeting our specific requirements.”
 
ComOps will integrate with Enterix’s existing Patient Database system with a customised front end to enable Enterix to report and provide analytics on standard business processes, including revenue, product sales by category, and other information.
 
Enterix expects to go live with the solution by the end of 2008.